Dr. Monique Hinchcliff is Director of Clinical and Translational Research for Rheumatology, Allergy & Immunology at the Yale School of Medicine and the Director of the Yale Scleroderma Program. She received her medical degree from the Rosalind Franklin University Chicago Medical School and completed her medicine residency at Norwalk Hospital in Connecticut. She completed rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, IL while earning a Master of Science degree in Clinical Investigation.
Her research program includes clinical, interventional and observational studies, with the goal of better understanding systemic sclerosis and identifying new and repurposed treatments for patients with systemic sclerosis. She has may active research collaborations both in the US and abroad. Clinically, Dr. Hinchcliff leads a team of multidisciplinary specialists with expertise in caring for patients with systemic sclerosis. She participates in ongoing clinical trials in order to give patients access to the latest treatments that may be beneficial.
Award | Awarding Organization | Date |
---|---|---|
Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Department of Medicine | 2018 |
Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2017 |
Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2016 |
Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2015 |
Organization | Role | Date |
---|---|---|
Scleroderma Clinical Trials Consortium | Member | 2007 - Present |
American College of Rheumatology | Member | 2006 - Present |
Scleroderma Foundation | Member | 2006 - Present |